Acute Migraine
24
0
0
17
Key Insights
Highlights
Success Rate
74% trial completion
Published Results
13 trials with published results (54%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
25.0%
6 terminated out of 24 trials
73.9%
-12.6% vs benchmark
42%
10 trials in Phase 3/4
76%
13 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (24)
A Study of K-645 in the Treatment of Multiple Migraine Attacks
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
Migraine Treatment With Nerivio Migra Neurostimulation Device
A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine
Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean
Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
Valproate Versus Ketorolac Versus Metoclopramide
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Transcranial Direct Current Stimulation for Migraine Attack
Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine
Chordate System S020 Acute Migraine Clinical Investigation
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
PBASE-system Acute Migraine Clinical Investigation